With Cancer Care, The U.S. Spends More, But Gets More | WAMU 88.5 - American University Radio

NPR : News

With Cancer Care, The U.S. Spends More, But Gets More

By now it's hardly news that the U.S. spends more than every other industrialized country on health care. But a new study suggests that at least when it comes to cancer care, Americans may actually be getting decent value.

The study, in April issue of the policy journal Health Affairs, isn't the first to suggest that U.S. patients do better than their European counterparts when it comes to surviving most types of cancer. Other studies have shown that the U.S. approves cancer drugs faster than most nations across the pond.

But this study, by researchers from the University of Chicago and the University of Southern California and partially funded by the cancer drugmaker Bristol-Myers Squibb, actually attempted to quantify what the U.S. gets for the additional money it spends.

And what it found is that for most types of solid tumor cancers, particularly breast and prostate cancer, even after considering the higher costs, U.S. patients experienced greater survival gains than patients in Europe.

And those costs did grow. Between 1983 and 1999, the period covered by the study, U.S. spending on cancer care grew 49 percent (in 2010 dollars). By comparison, spending in the 10 European countries included in the study grew by 16 percent. But for patients diagnosed between 1995 and 1999, average survival from time of diagnosis in the U.S. was 11.1 years, while in Europe it was 9.3 years.

"Using conservative market estimates of the value of a statistical life, this study presented evidence that U.S. cancer survival gains are worth more than the corresponding growth in the cost of U.S. cancer care according to the most recent data available for analysis," the study's authors wrote.

There are some significant caveats, of course. One is that that "most recent data" ends in 1999. And, they note, "important changes in cancer care have occurred in the past ten years, including the introduction of expensive new drug treatment and increased use of diagnostic imaging."

So, the authors point out, it will take still more research to determine if today's increased spending is still worth it, and what specific aspects of cancer care are driving the U.S.'s improved survival rates.

Copyright 2012 National Public Radio. To see more, visit http://www.npr.org/.

NPR

'Guardians' Director: This Movie Needed Me!

Morning Edition's David Greene talks to director James Gunn about his new film, Guardians of the Galaxy, which Marvel hopes to make its next big franchise. Characters include a raccoon and a tree.
NPR

Syracuse Researchers Melt Rock, Grill A Steak Over Magma

Researchers at the university built a furnace that can melt rock, then had a cookout. Chefs placed a ribeye on a grill over the 2,100-degree magma. Seconds later, a very charred, medium rare steak.
NPR

Cantor To Step Down This Month To Make Room For Successor

After relinquishing his majority leader post, Cantor, who was defeated in a stunning June primary upset, says he wants to make room for his successor to take over his Virginia seat in November.
NPR

Big Data Firm Says It Can Link Snowden Data To Changed Terrorist Behavior

For months, U.S. officials have said secret data from former NSA contractor Edward Snowden was affecting the way terrorists communicate. A Massachusetts company says it has found proof.

Leave a Comment

Help keep the conversation civil. Please refer to our Terms of Use and Code of Conduct before posting your comments.